1. Home
  2. LSCC vs HALO Comparison

LSCC vs HALO Comparison

Compare LSCC & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lattice Semiconductor Corporation

LSCC

Lattice Semiconductor Corporation

HOLD

Current Price

$74.38

Market Cap

9.6B

Sector

Technology

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$67.61

Market Cap

7.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LSCC
HALO
Founded
1983
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
7.4B
IPO Year
1989
N/A

Fundamental Metrics

Financial Performance
Metric
LSCC
HALO
Price
$74.38
$67.61
Analyst Decision
Strong Buy
Buy
Analyst Count
11
12
Target Price
$76.18
$73.33
AVG Volume (30 Days)
1.7M
2.2M
Earning Date
02-09-2026
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
56.68
EPS
0.20
4.74
Revenue
$494,889,000.00
$1,242,852,000.00
Revenue This Year
$4.23
$34.83
Revenue Next Year
$21.23
$24.84
P/E Ratio
$375.93
$14.56
Revenue Growth
N/A
31.19
52 Week Low
$34.69
$47.50
52 Week High
$81.23
$79.50

Technical Indicators

Market Signals
Indicator
LSCC
HALO
Relative Strength Index (RSI) 51.70 52.99
Support Level $71.27 $67.95
Resistance Level $77.00 $69.48
Average True Range (ATR) 2.24 1.61
MACD -0.36 0.58
Stochastic Oscillator 35.69 77.29

Price Performance

Historical Comparison
LSCC
HALO

About LSCC Lattice Semiconductor Corporation

Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia. It also has its presence in Americas and Europe.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: